Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Immunocore Holdings plc - American Depositary Shares
(NQ:
IMCR
)
31.69
-0.06 (-0.19%)
Streaming Delayed Price
Updated: 3:40 PM EDT, Jul 1, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Immunocore Holdings plc - American Depositary Shares
< Previous
1
2
3
4
5
6
7
Next >
What Analysts Are Saying About Immunocore Hldgs Stock
↗
February 27, 2025
Via
Benzinga
Immunocore reports fourth quarter and full year 2024 financial results and provides a business update
February 26, 2025
From
Immunocore Holdings plc
Via
GlobeNewswire
Earnings Scheduled For February 26, 2025
↗
February 26, 2025
Via
Benzinga
Immunocore to report fourth quarter and full year 2024 financial results and host call on February 26, 2025
February 19, 2025
From
Immunocore Holdings plc
Via
GlobeNewswire
Analyst Expectations For Immunocore Hldgs's Future
↗
January 27, 2025
Via
Benzinga
Navigating 8 Analyst Ratings For Immunocore Hldgs
↗
November 11, 2024
Via
Benzinga
A Closer Look at 9 Analyst Recommendations For Immunocore Hldgs
↗
October 24, 2024
Via
Benzinga
Analyst Ratings For Immunocore Hldgs
↗
October 07, 2024
Via
Benzinga
Immunocore announces strategic priorities at 43rd Annual J.P. Morgan Healthcare Conference
January 10, 2025
From
Immunocore Holdings plc
Via
GlobeNewswire
Immunocore to present at the 43rd Annual J.P. Morgan Healthcare Conference
January 06, 2025
From
Immunocore Holdings plc
Via
GlobeNewswire
Immunocore appoints Travis Coy, previously a Non-Executive Director, as its EVP, Chief Financial Officer and Head of Corporate Development
January 02, 2025
From
Immunocore Holdings plc
Via
GlobeNewswire
Immunocore announces first patient dosed in the Phase 1 trial of IMC-P115C, a half-life extended (HLE) ImmTAC candidate in patients with tumors that express PRAME
December 23, 2024
From
Immunocore Holdings plc
Via
GlobeNewswire
Analyst Expectations For Immunocore Hldgs's Future
↗
September 17, 2024
Via
Benzinga
The Latest Analyst Ratings For Immunocore Hldgs
↗
August 28, 2024
Via
Benzinga
Immunocore announces treatment of first patient in the Phase 1/2 trial of IMC-R117C targeting PIWIL1 in advanced gastrointestinal cancers
December 17, 2024
From
Immunocore Holdings plc
Via
GlobeNewswire
Why Are Amicus, Immunocore, & Immuneering Stocks Trading Lower On Friday?
↗
December 13, 2024
Morgan Stanley downgrades Amicus Therapeutics, Immunocore, and Immuneering, citing pricing challenges, pipeline updates, and cautious growth outlooks.
Via
Benzinga
EORTC and Immunocore announce enrolment of first patient onto the only active Phase 3 adjuvant trial in uveal melanoma
December 11, 2024
From
Immunocore Holdings plc
Via
GlobeNewswire
Immunocore announces reimbursement agreement in England for KIMMTRAK▼ for the treatment of HLA-A*02:01-positive adults with unresectable or metastatic uveal melanoma
December 03, 2024
From
Immunocore Holdings plc
Via
GlobeNewswire
Deep Dive Into Immunocore Hldgs Stock: Analyst Perspectives (9 Ratings)
↗
August 09, 2024
Via
Benzinga
Peeling Back The Layers: Exploring Immunocore Hldgs Through Analyst Insights
↗
July 10, 2024
Via
Benzinga
3 Fast-Growing Stocks Analysts See Doubling in Price
November 11, 2024
Clinical-stage biotech firms often have massive upside potential, but much of that possible success hinges on successful trials and product launches.
Via
MarketBeat
Immunocore to present at upcoming investor conferences
November 08, 2024
From
Immunocore Holdings plc
Via
GlobeNewswire
Immunocore reports third quarter financial results and provides a business update
November 06, 2024
From
Immunocore Holdings plc
Via
GlobeNewswire
GE Vernova To Rally Over 30%? Here Are 10 Top Analyst Forecasts For Tuesday
↗
September 17, 2024
Via
Benzinga
Immunocore presents Phase 1 data of brenetafusp, an ImmTAC bispecific targeting PRAME, in patients with ovarian cancer
September 14, 2024
From
Immunocore Holdings plc
Via
GlobeNewswire
Immunocore to present at the 2024 Cantor Global Healthcare Conference
September 12, 2024
From
Immunocore Holdings plc
Via
GlobeNewswire
Immunocore announces transition of Chief Financial Officer
August 29, 2024
From
Immunocore Holdings plc
Via
GlobeNewswire
Immunocore reports second quarter financial results and provides a business update
August 08, 2024
From
Immunocore Holdings plc
Via
GlobeNewswire
3 Small-Cap Stocks with Significant Growth Potential
↗
August 06, 2024
As sector rotation continues, it could be time for investors to consider these small-cap growth stocks that institutions love.
Via
InvestorPlace
Immunocore to report second quarter 2024 financial results and host call on August 8, 2024
August 01, 2024
From
Immunocore Holdings plc
Via
GlobeNewswire
< Previous
1
2
3
4
5
6
7
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
